The Latest Breaking News from Benzinga

Tortoise Capital Advisors has debuted the Tortoise AI Infrastructure ETF (NYSE:TCAI), its latest actively managed fund that invests in the infrastructure underpinning the AI revolution.

If 2025’s economic narratives had an underdog, it could very well be deregulation, and the Free Markets ETF (NYSE:FMKT) is positioning itself to capitalize on its full potential before it's fully recognized by the broader market.

The hit animated series "South Park," which is back for its 27th season, wasted no time making fun of President Donald Trump and the ongoing legal saga between the president and Paramount Global (NASDAQ:PARA) (NASDAQ:PARAA) that owns the rights to the show.

Inspire Medical Systems, Inc. (NYSE:INSP) stock is plunging after the company released its second-quarter earnings and cut its annual guidance.

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday.

Shift4 Payments (NYSE:FOUR) stock plunged Tuesday after it reported fiscal second-quarter 2025 results.

Fellow Health just raised $24 million in a Series B funding round, bringing its cash haul across multiple offerings to $48 million. The San Leandro, California startup advances male reproductive health through "patient-centric testing solutions" and plans to use the capital infusion to expand its mail-in semen analysis services.  

ZetaChain's (CRYPTO: ZETA) latest integration with the Sui (CRYPTO: SUI) blockchain could bring real capital flows and application-level traction from native Bitcoin (CRYPTO: BTC), not just infrastructure optics, according to Jonathan Covey, a core contributor at ZetaChain.

On Tuesday, Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) reported second-quarter adjusted earnings of $1.44, up 50% year over year, beating the consensus of 85 cents and sales of $825.41 million, up 16%, beating the consensus of $760.39 million.